Rapport Therapeutics, Inc. (RAPP)
Market Open
26 Oct, 06:11 PM
NASDAQ (NMS) NASDAQ (NMS) Primary $
25. 88
-0.05
-0.1928%
$
1.32B Market Cap
- P/E Ratio
- Div Yield
35,145 Volume
- Eps
$ 25.93
Previous Close 
Want to track RAPP and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
RAPP Earnings Reports FAQ
What is the earnings per share (EPS) for RAPP?
EPS data for RAPP is currently not available, as Rapport Therapeutics, Inc has not reported recent earnings.
What is the company's earnings growth rate?
Rapport Therapeutics, Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Rapport Therapeutics, Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Rapport Therapeutics, Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for RAPP at this time, as Rapport Therapeutics, Inc has no recent EPS data to calculate it.
2026 © Marketlog. All Rights Reserved.
